Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Sun Pharmaceutical Industries is recalling 31,762 bottles of Bupropion Hydrochloride Extended-Release Tablets because they failed dissolution specifications.
Biocompatibles is recalling Varithena administration packs because they contain the incorrect type of syringe. The recall covers 3,254 packs distributed nationwide.
Shire is recalling 7,680 bottles of Vyvanse 30 mg capsules because foreign tablets or capsules were found in the product.
Pharmacy Plus, Inc. is recalling Pre-Op Pledget Soln + Tetracaine vials because the agency cannot ensure the product is sterile.
Pharmacy Plus, Inc. is recalling 139 vials of Hydroxyzine HCl injection in Mississippi due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling Buprenorphine 0.6 mg/ml Injection due to lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 62 vials of Trypan Blue 0.3% due to a lack of assurance of sterility.
The FDA is recalling Autologous Serum Tears from Vital Care Compounder due to a lack of assurance of sterility. The product was distributed in Mississippi.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling C-PAP/PHEN/PROST/ATROP 150/5/5 injection vials due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling C-PAP/PHEN/PROST/Atrop 150/7.5 injection vials due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling Apomorphine HCl 3mg/ml Sterile Injection Solution due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 23 vials of Hyaluronidase due to a lack of assurance of sterility. The affected lot was distributed in Mississippi.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 108 vials of Chlorpheniramine Maleate 10 mg/ml due to lack of assurance of sterility.
Pharmacy Plus, Inc. is recalling Morphine Sulfate 15mg/ml Injection due to a lack of assurance of sterility. The product was distributed in Mississippi.
Pharmacy Plus, Inc. is recalling Methylcobalamin 5,000mcg/ml vials due to lack of assurance of sterility. The recall affects 36 vials distributed in Mississippi.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling Olopatadine 0.8% Ophthalmic Solution due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling specific lots of Papaverine 150 mg / Phentolamine 5 mg vials due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 14 vials of Brilliant Blue G 0.025% due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling specific lots of Papaverine and Prostaglandin vials due to a lack of assurance of sterility.
The FDA is recalling specific lots of MOXI/DEX/KETOROLAC eye drops from Vital Care Compounder due to a lack of assurance of sterility.
Pharmacy Plus, Inc. is recalling Pre-Op Pledget Soln ophthalmic drops due to a lack of assurance of sterility. The recall affects 6 vials distributed in Mississippi.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling specific lots of Moxifloxacin and Dexamethasone ophthalmic vials due to a lack of assurance of sterility.
Pharmacy Plus, Inc. dba Vital Care Compounder is recalling 16 vials of Moxifloxacin HCl eye drops due to a lack of assurance of sterility.
Pharmacy Plus, Inc. is recalling specific lots of DMSO 50% with Lidocaine 0.5% vials due to a lack of assurance of sterility.
Pharmatech LLC is recalling Senexon Liquid (sennosides) 8.8 mg bottles nationwide as a precautionary measure due to a potential risk of contamination with B. cepacia bacteria.